Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

164
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
164
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

1.6K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.6K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

665
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
665
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

745
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
745
The Endocrine System01:29

The Endocrine System

297
The endocrine system is an extensive network of glands – organs or tissues in the body that create chemicals that control many bodily functions, that secrete hormones, which are chemical messengers that play essential roles in regulating various bodily functions. These hormones are secreted into the bloodstream and travel throughout the body. They require specific receptors to convey signals to cells possessing these corresponding receptors. This complex signaling mechanism ensures that...
297
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

1.5K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronicity and comorbidities: Is estimated longer duration of obstructive sleep apnoea linked to higher cardiometabolic risk?

Lung India : official organ of Indian Chest Society·2026
Same author

Relative Adrenal Insufficiency is Associated With Worse Clinical Outcomes in Patients With Acute Decompensation of Cirrhosis and Hyponatremia.

Journal of clinical and experimental hepatology·2026
Same author

Tumor-Induced Osteomalacia: A Case Report of Rare Disease and Literature review.

South Asian journal of cancer·2025
Same author

Change in apnea hypopnea index and sleep quality following treatment in acromegaly.

Endocrine research·2025
Same author

GnRH agonist-induced ovarian hyperstimulation: A diagnostic clue to pituitary adenoma.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2025
Same author

Letter to the Editor Regarding 'Profile of Metabolic Dysfunction-Associated Steatotic Liver Disease: Mapping Across Different Indian Populations (MAP Study)'.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2025

Related Experiment Video

Updated: Jul 6, 2025

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
07:12

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

6.7K

Dyslipidaemia in endocrine disorders.

Kalyani Sridharan1, Sanjay Kalra2

  • 1Department of Endocrinology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

Indian Heart Journal
|December 31, 2023
PubMed
Summary

Lipid disorders frequently accompany endocrine conditions like diabetes and hypothyroidism. Treating the underlying endocrine issue is key to managing dyslipidemia and reducing cardiovascular risk.

Keywords:
Endocrine disordersLipid disordersdyslipidemia

More Related Videos

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.0K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K

Related Experiment Videos

Last Updated: Jul 6, 2025

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
07:12

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

6.7K
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.0K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K

Area of Science:

  • Endocrinology
  • Metabolic Health
  • Cardiovascular Disease Risk

Background:

  • Lipid disorders, or dyslipidemia, are prevalent in various endocrine conditions.
  • Common endocrine disorders associated with dyslipidemia include diabetes mellitus, hypothyroidism, and Cushing's syndrome.
  • Dyslipidemia significantly impacts endocrine and metabolic health, increasing atherosclerotic cardiovascular disease risk.

Purpose of the Study:

  • To highlight the association between endocrine disorders and dyslipidemia.
  • To emphasize the importance of clinical signs in suspecting endocrine diseases in dyslipidemia cases.
  • To outline the management strategies for lipid disorders in the context of endocrine diseases.

Main Methods:

  • Review of common endocrine disorders linked to dyslipidemia.
  • Emphasis on clinical assessment for identifying underlying endocrine causes.
  • Integration of lipid-lowering therapies with endocrine condition management.

Main Results:

  • Endocrine conditions are frequent causes of dyslipidemia.
  • Clinical symptoms and signs are crucial for diagnosing associated endocrine disorders.
  • Management requires addressing the primary endocrine condition, often supplemented by lipid-lowering therapy.

Conclusions:

  • Optimal dyslipidemia management in endocrine disease necessitates treating the underlying condition.
  • Lipid-lowering therapy serves as a vital adjunct or requirement.
  • Indian guidelines offer a practical framework for managing lipid disorders in endocrine disease and promoting endocrine awareness during lipid therapy.